Skip to main navigation Skip to search Skip to main content

Some uses of transition metal complexes as anti-cancer and anti-HIV agents

  • Raymond Wai Yin Sun
  • , Dik Lung Ma
  • , Ella Lai Ming Wong
  • , Chi Ming Che*
  • *Corresponding author for this work

Research output: Contribution to journalJournal articlepeer-review

235 Citations (Scopus)

Abstract

The success of the clinical uses of cisplatin, cis-[PtII(NH 3)2Cl2], has stimulated considerable interest in using other metal complexes as new therapeutic agents. This perspective describes our recent work on several classes of gold(iii), platinum(ii), ruthenium(ii, iii, iv), iron(ii) and vanadium(iv) complexes for anti-cancer and anti-HIV treatments.

Original languageEnglish
Pages (from-to)4884-4892
Number of pages9
JournalDalton Transactions
Issue number43
DOIs
Publication statusPublished - Sept 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Some uses of transition metal complexes as anti-cancer and anti-HIV agents'. Together they form a unique fingerprint.

Cite this